3. • Standardised guidance
• Evidence-based management
• Fast and easy to refer
• Simple and comprehensive
• Enhance familiarization of management
Pathways
4.
5. 1. Cervical Screening & Colposcopy Pathways
2. Management of Cervical Cancer Pathways
3. Management of Endometrial Hyperplasia Pathways
4. Management of OvarianTumour Pathways
5. Management of Pregnancy of Unknown Location Pathways
SGH Gynaecological Management Pathways
7. 1.Cervical screening and referral
2.Abnormal uterine bleeding and referral
3.Ovarian tumour and referral
Content
8.
9.
10. Cervical Screening
Cervical Screening Intervals
A sexually active woman aged ≥ 25 years old should be offered yearly cervical screening
initially, and if she has consecutive yearly normal cervical smears x2, routine screening (3 yearly/ 5yearly
based on the age) is required thereafter.
Age Group
(Years)
Routine Screening Intervals
25-49 3 yearly
50-65 5 yearly
>65 Only screen those who have not been
screened since age of 50 and who have had
a recent abnormal smear
11. Cytology Regression at 24 months Progression to HGSIL
at 24 months
Progression to invasive
cancer at 24 months
ASCUS 68.2% 7.1% 0.3%
LGSIL 47.4% 20.8% 0.2%
HGSIL 35.0% 23.4% (persistence) 1.4%
CIN Regression Persistence Progression
to CIN3
Progression to invasive
cancer
CIN 1 57% 32% 11% 1%
CIN 2 43% 35% 22% 1.5%
CIN 3 32% 56% - 12%
Natural History of Abnormal Cytology
Natural History of Cervical Intraepithelial Neoplasia (CIN)
12. Terminologies
• Cervical smear
• Pap smear, liquid based cytology
• To detect precancerous cells
• HPV triage
• Virology testing to detect high risk HPV virus (16, 18, 31, 45)
• Colposcopy
• Examination under magnification
• Cervical intraepithelial neoplasia (CIN)
• Histology diagnosis (Biopsy) of the premalignant transformation of
cervix
17. Treatment for Abnormal Organisms
• BacterialVaginosis
• T. Metronidazole 400mg BD x 1/52
• Trichomonas vaginalis
• T. Metronidazole 400mg BD x 1/52
• Treat the partner
• Vaginal candidiasis
• Clotrimazole pessary 200mg ON x 3/7
18. General Rules for
Management of Abnormal
Cervical Smear
Squamous Cell
Abnormalities
Glandular Cell
Abnormalities
• Unsatisfactory smear
Repeat in 3 months, if still unsatisfactory → colposcopy
(non-urgent)
• Inflammatory smear
Treat infection or atrophy
Repeat in 6 months
If inflammatory smear x 3 → colposcopy (non-urgent)
• Atypical squamous cells of undetermined significance (ASCUS)
HPV triage/repeat smear in 6 months/colposcopy (non-
urgent)
• Low-grade squamous intraepithelial lesion (LGSIL)
Colposcopy (non-urgent)
• High-grade squamous intraepithelial lesion (HGSIL)
Colposcopy (urgent)
• Atypical squamous cells – cannot exclude HGSIL (ASC – H)
Colposcopy (urgent)
• Squamous cell carcinoma
Refer gynae-oncologist urgent
• Atypical glandular cells not otherwise specified
(AGC – NOS)
Colposcopy (non-urgent) + endocervical
curettage ± endometrial sampling
• Atypical glandular cells favour neoplasia
Colposcopy (urgent) + cone biopsy +
hysteroscopy and endometrial curettage
• Endocervical adenocarcinoma-in-situ
Colposcopy (urgent) + cone biopsy
• Adenocarcinoma
Refer gynae-oncologist urgent
5-yr cancer risk: 8%
5-yr cancer risk: 2%
1/3 – 2/3 are non-HPV related
19. WHENEVERTHERE ISAN
ABNORMAL SUSPICIOUS LOOKING GROWTH
OVERTHE CERVIX,
REFER O&G SPECIALIST URGENT
FOR ASSESSMENTAND BIOPSY!!!!!
(DO NOT PROCEEDWITH PAP SMEAR ONLY)
20. Case Scenario
• 35 year-old woman went to KK for
routine pap smear. Speculum
showed a mass 2x2 cm over
anterior lip of cervix. Pap smear
was done.
25. HISTORY Menstrual history
Associated Symptoms: Compressive symptoms, Anaemia
symptoms, Symptoms suggestive of systemic causes
(hypothyroid, bleeding disorders, polycystic ovarian
syndrome), PID
Cervical smear history
Contraception history
Sexual history and fertility desire
Family history of malignancy/bleeding disorders
Past medical history
Past surgical history
Drug history: over-the-counter or natural/herbal remedies
(may interfere ovulation/associated with bleeding) –
anticoagulants, antidepressants, antipsychotic,
corticosteroids, Tamoxifen, ginseng
26. PHYSICAL
EXAMINATION
General: pale, bruises, body mass index (BMI), blood pressure, pulse rate
Abdomen: mass/uterus
Speculum: cervix/vagina mass
Bimanual examination of uterus and adnexal structures
INVESTIGATIONS Urine pregnancy test
Full blood count Coagulation profile
Anaemic workup: peripheral blood film, serum iron + ferritin, serum folate, serum B12,
Hb electrophoresis
Hormonal profile
Transabdominal/vaginal scan: uterus size, fibroids, endometrial thickness, polyps,
ovarian cyst, hydrosalpinx
Cervical smear
Endometrial sampling (pipelle sampling can detect over 90% of endometrial cancer)
o Age >40,
o Younger women with risk factors (BMI>30, nulliparity, PCOS, DM, HNPCC,
oligomenorrhoea suggestive of anovulation)
o Failure of medical treatment,
o Intermenstrual bleed,
27. 1. Structural abnormality requiring surgery (polyps, big fibroids)
2. Suspecting malignancy (postmenopausal bleed, thickened ET,
cervical mass)
3. Failed to response to medical treatment
4. Endocrinology disorders: Refer medical team
When do you refer??